BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 3404446)

  • 1. Reversal of inhibition of prolactin secretion in cultured pituitary cells by muscarinic antagonists.
    Beach JE; Smallridge RC; Chiang PK; Fein HG
    J Pharmacol Exp Ther; 1988 Aug; 246(2):548-52. PubMed ID: 3404446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of in vitro actions with behavioral effects of antimuscarinic agents.
    Witkin JM; Gordon RK; Chiang PK
    J Pharmacol Exp Ther; 1987 Sep; 242(3):796-803. PubMed ID: 3498817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential involvement of protein kinase C in basal versus acetylcholine-regulated prolactin secretion in rat anterior pituitary cells during aging.
    Pu HF; Liu TC
    J Cell Biochem; 2002; 86(2):268-76. PubMed ID: 12111996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of muscarinic pharmacophores on the cholinergic regulation of catecholamine secretion from perfused adrenal glands.
    Nakazato Y; Oleshansky MA; Chiang PK
    Arch Int Pharmacodyn Ther; 1988; 293():209-18. PubMed ID: 3421778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro.
    Bowden CR; Voina SJ; Woestenborghs R; De Coster R; Heykants J
    J Pharmacol Exp Ther; 1992 Aug; 262(2):699-706. PubMed ID: 1380082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation and inhibition of prolactin release by prolactin-releasing Peptide in rat anterior pituitary cell aggregates.
    Swinnen E; Boussemaere M; Denef C
    J Neuroendocrinol; 2005 Jun; 17(6):379-86. PubMed ID: 15929743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The muscarinic antagonists aprophen and benactyzine are noncompetitive inhibitors of the nicotinic acetylcholine receptor.
    Amitai G; Herz JM; Bruckstein R; Luz-Chapman S
    Mol Pharmacol; 1987 Nov; 32(5):678-85. PubMed ID: 3683366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depolarization counteracts glucocorticoid inhibition of adenohypophysical corticotroph cells.
    Lim MC; Shipston MJ; Antoni FA
    Br J Pharmacol; 1998 Aug; 124(8):1735-43. PubMed ID: 9756391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of some diphenyl-substituted antimuscarinics: comparison with cocaine and atropine.
    Witkin JM; Genovese RF; Witkin KM; Chiang PK
    Pharmacol Biochem Behav; 1992 Feb; 41(2):377-84. PubMed ID: 1574528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ergovaline, loline, and dopamine antagonists on rat pituitary cell prolactin release in vitro.
    Strickland JR; Cross DL; Birrenkott GP; Grimes LW
    Am J Vet Res; 1994 May; 55(5):716-21. PubMed ID: 8067623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agnus castus extracts inhibit prolactin secretion of rat pituitary cells.
    Sliutz G; Speiser P; Schultz AM; Spona J; Zeillinger R
    Horm Metab Res; 1993 May; 25(5):253-5. PubMed ID: 8330858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant role of 5 alpha-reductase on feedback effects of androgen in rat anterior pituitary cells demonstrated with a nonsteroidal 5 alpha-reductase inhibitor ONO-3805.
    Nagamoto A; Noguchi K; Murai T; Kinoshita Y
    J Androl; 1994; 15(6):521-7. PubMed ID: 7721654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central neuropeptide B administration activates stress hormone secretion and stimulates feeding in male rats.
    Samson WK; Baker JR; Samson CK; Samson HW; Taylor MM
    J Neuroendocrinol; 2004 Oct; 16(10):842-9. PubMed ID: 15500544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of peptide YY(3-36) on PRL secretion: pituitary and extra-pituitary actions in the rat.
    Aguilar E; Fernandez-Fernandez R; Tena-Sempere M; Pinilla L
    Peptides; 2004 Jul; 25(7):1147-52. PubMed ID: 15245874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influences of GnRH, oxytocin and vasoactive intestinal peptide on LH and PRL secretion by porcine pituitary cells in vitro.
    Bogacka I; Siawrys G; Okrasa S; Kaminski T; Przala J
    J Physiol Pharmacol; 2002 Sep; 53(3):439-51. PubMed ID: 12369740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-aminobutyric acid (GABA)-C receptor stimulation increases prolactin (PRL) secretion in cultured rat anterior pituitary cells.
    Nakayama Y; Hattori N; Otani H; Inagaki C
    Biochem Pharmacol; 2006 Jun; 71(12):1705-10. PubMed ID: 16677614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
    Enjalbert A; Bockaert J
    Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Methyl-6-azabicyclo[3.2.1]octan-3 alpha-ol 2,2-diphenylpropionate (azaprophen), a highly potent antimuscarinic agent.
    Carroll FI; Abraham P; Parham K; Griffith RC; Ahmad A; Richard MM; Padilla FN; Witkin JM; Chiang PK
    J Med Chem; 1987 May; 30(5):805-9. PubMed ID: 3494849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lowering of cytosolic free Ca2+ by carbachol, a muscarinic cholinergic agonist, in clonal pituitary cells (GH3 cells).
    Schlegel W; Wuarin F; Zbaren C; Zahnd GR
    Endocrinology; 1985 Sep; 117(3):976-81. PubMed ID: 3926473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.